DPA
EW icon

Delphi Private Advisors’s Edwards Lifesciences EW Stock Holding History

Delphi Private Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-48
Closed -$1K – 170
2016
Q4 		$1K Hold
48
– – ﹤0.01% 218
2016
Q3 		$2K Hold
48
– – ﹤0.01% 255
2016
Q2 		$2K Hold
48
– – ﹤0.01% 265
2016
Q1 		$1K Hold
48
– – ﹤0.01% 267
2015
Q4 		$1K Buy
+48
New +$1.25K ﹤0.01% 311

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Delphi Private Advisors's EW Position: Q1 2017 in Review

Delphi Private Advisors sold out of Edwards Lifesciences (EW) in Q1 2017, closing a stake of 48 shares — an estimated $1K sold.

Delphi Private Advisors first reported a position in EW in Q4 2015 and held it in 5 quarters. The position peaked at $2K in Q3 2016. 691 funds tracked by Wall St. Rank hold EW as of Q1 2017.

  • Delphi Private Advisors reported no remaining Edwards Lifesciences position as of Q1 2017 after selling out during the quarter.
  • Delphi Private Advisors sold 48 Edwards Lifesciences shares in Q1 2017, an estimated $1K.
  • Delphi Private Advisors first reported a position in Edwards Lifesciences in Q4 2015 and held it in 5 quarters.
  • Delphi Private Advisors's Edwards Lifesciences position peaked at $2K in Q3 2016.
  • 691 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2017.

Based on Delphi Private Advisors's 13F filing for Q1 2017, filed 25 Apr 2017.